Treatment of inoperable hepatocellular carcinoma with immunotherapy
Sign Up to like & getrecommendations! Published in 2019 at "BMJ Case Reports"
DOI: 10.1136/bcr-2019-229744
Abstract: In the USA, mortality associated with hepatocellular carcinoma (HCC) continues to rise. Globally, HCC is the third most common cause of cancer-related death. In early stages of HCC, hepatic resection or liver transplantation are the… read more here.
Keywords: hepatocellular carcinoma; treatment inoperable; immunotherapy; treatment ... See more keywords